Work

A co-clinical phase II trial of carboplatin and docetaxel as neoadjuvant treatment for triple negative breast cancer with genomic discovery analysis.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.tps1099

Authors: Foluso Olabisi Ademuyiwa, Shunqiang Li, Tracy Skinner, Jason Hoshower, Jingqin Luo, Cynthia X. Ma, Katherine N. Weilbaecher, Michael Naughton, Leonel Fernando Hernandez-Aya, Elaine R. Mardis, Matthew James Ellis

Institutions: Washington University in St. Louis, Baylor College of Medicine

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2696814975

Cites:

Cited by: 1

Related to: 10